The purpose of this study is to assess the feasibility of a full-scale multicenter randomized, controlled trial comparing the effectiveness of two surgical treatments for a condition associated with lumbar spinal stenosis called degenerative lumbar spondylolisthesis. Both treatments are currently used, but individual surgeons use different selection criteria for each treatment and use the procedures at different rates. The two procedures are decompression with fusion (the most common surgical procedure for spondylolisthesis) and midline-sparing decompression alone (which is also a standard treatment, but is not as widely used for treating spondylolisthesis). The investigators plan to collect the evidence on the following: 1. The feasibility of the trial protocol, and 2. Preliminary data on the effectiveness of each treatment.
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Enrollment
70
Foothills Medical Centre
Calgary, Alberta, Canada
Mackenzie Health Sciences Centre
Edmonton, Alberta, Canada
Vancouver General Hospital
Vancouver, British Columbia, Canada
Queen Elizabeth II Health Sciences Centre
Halifax, Nova Scotia, Canada
London Health Sciences Centre - Victoria Hospital
London, Ontario, Canada
Sunnybrook Health Sciences Centre
Toronto, Ontario, Canada
University Health Network
Toronto, Ontario, Canada
Montreal General Hospital
Montreal, Quebec, Canada
Number of patients recruited
Time frame: 1 year
Number of eligible patients
Time frame: 1 year
Reasons for refusal to consent
Time frame: 1 year
Proportion of patients who adhere to randomized allocation
Time frame: 2 years
Number of patients refusing to consent due to blinding
Time frame: 1 year
Blinding status
Patient's assessment of which treatment they received
Time frame: 1.5 months post-surgery
Oswestry Disability Index (ODI)
10-item patient-reported questionnaire measuring disability related to low back pain. Each item has six response options ranging from 0 to 5; the responses are summed and rescaled so 0 indicates no disability and 100 indicates extreme disability.
Time frame: 6-18 weeks, 6 months (optional), 12 months, and 24 months post-surgery
Proportion of patients who receive randomized allocation
Time frame: 2 years
Number of patients refusing to consent due to randomization
Time frame: 1 year
Number, type and severity of adverse events
Time frame: End of hospital stay (average 6.5 days post-surgery)
Short-Form 12 scores: Physical Function, Bodily Pain, Physical Component Summary
12-item patient-reported questionnaire for general health status based on the SF-36 Health Survey (version 2). Measures eight health domains, each scored so 0 is the worst and 100 is the best possible score: general health (GH), physical function (PF), bodily pain (BP), role limitations due to physical problems (RP), role limitations due to emotional problems (RE), mental health (MH), social functioning (SF), and energy/fatigue (VT). The domain scores can be aggregated into Physical Component Summary (PCS) and Mental Component Summary (MCS) scores, also scaled so 0 is the worst and 100 is the best possible score. This study will focus primarily on the Physical Function domain, the Bodily Pain domain, and the Physical Component Summary score.
Time frame: Baseline; 6-18 weeks, 6 months (optional), 12 months, and 24 months post-surgery
Euro-QoL health utility index
Patient-reported questionnaire for general health state which includes five items (mobility, self-care, usual activities, pain/discomfort, and anxiety/depression) and a visual analog scale for self-rated health state. Using an existing U.S. population-based value set, responses will be converted to the corresponding health utility index (1.0=perfect health and 0.0=death).
Time frame: Baseline; 6-18 weeks, 6 months (optional), 12 months, and 24 months post-surgery
Patient Health Questionnaire-9 score
Patient-reported questionnaire that measures severity of depression symptoms. It is scored from 0 to 27, with the following interpretation: 0-4=no symptoms, 5-9=minimal symptoms; 10-14=mild/minor depression or dysthymia; 15-19=moderate major depression; 20-27=severe major depression.
Time frame: Baseline
Costs incurred by patients
Time frame: monthly from 1.5 to 12 months post-surgery; 24 months post-surgery
Hospital cost
Time frame: End of hospital stay (average 6.5 days post-surgery)
Healthcare services used
Other Ontario Health Insurance Plan (OHIP)-billed services used
Time frame: Referral to 1 year post-surgery
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.